Business Context and Reporting Period
CareTrust REIT, Inc. (CTRE) filed a Form 8-K on May 20, 2026, reporting a significant capital raising event. The filing details the execution of a forward sale agreement involving the offer and sale of common stock, with the closing of the optional portion occurring on May 21, 2026.
Key Financial Metrics
This filing reports on a specific equity transaction rather than periodic operating results. Key transaction metrics include:
- Firm Shares Sold: 12,500,000 shares of Common Stock.
- Optional Shares Sold: 1,875,000 shares of Common Stock (Option exercised in full).
- Total Shares Issued: 14,375,000 shares.
- Offering Price: $40.225 per share.
- Underwriters: Wells Fargo Securities, LLC and J.P. Morgan Securities LLC.
- Forward Purchasers: Wells Fargo Bank, National Association and JPMorgan Chase Bank, National Association.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics as this is a transactional report, not a financial statement.
Material Changes
The primary material change is the full exercise of the underwriters' option to purchase an additional 1,875,000 shares. This action increased the total capital raised from the offering beyond the initial firm commitment. The transaction was structured as a forward sale, where forward purchasers borrowed shares to sell to underwriters, and the company subsequently sold the shares to the forward sellers.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management outlook, or specific risk factors beyond the standard disclosures inherent in the transaction. The document notes that the description of the Additional Forward Sale Agreements is qualified by the full text of the agreements filed as Exhibits 1.1 and 1.2. Legal validity of the shares was confirmed by an opinion from DLA Piper LLP (US).
Investor Verification Checklist
- Verify the total gross proceeds calculated from 14,375,000 shares at $40.225 per share.
- Review the full text of the Forward Sale Agreements (Exhibits 1.1 and 1.2) for specific terms, fees, and conditions.
- Confirm the impact of this equity issuance on the company's share count and potential dilution.
- Check subsequent filings for the actual cash proceeds received after deducting underwriting discounts and commissions.